The predictive and prognostic significance of pre- and post-treatment topoisomerase IIα in anthracycline-based neoadjuvant chemotherapy for local advanced breast cancer. [electronic resource]
Producer: 20130708Description: 619-26 p. digitalISSN:- 1532-2157
- Adult
- Aged
- Analysis of Variance
- Anthracyclines -- administration & dosage
- Antigens, Neoplasm -- analysis
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- DNA Topoisomerases, Type II -- analysis
- DNA-Binding Proteins -- analysis
- Disease-Free Survival
- Female
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Logistic Models
- Lymph Node Excision
- Mastectomy -- methods
- Middle Aged
- Neoadjuvant Therapy -- methods
- Predictive Value of Tests
- Prognosis
- Proportional Hazards Models
- Receptor, ErbB-2 -- analysis
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.